We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

243 hedge funds and large institutions have $15.7B invested in BeOne Medicines Ltd in 2020 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 114 increasing their positions, 55 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

463% more call options, than puts

Call options by funds: $46.9M | Put options by funds: $8.32M

167% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 15

107% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 55

66% more capital invested

Capital invested by funds: $9.45B → $15.7B (+$6.26B)

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

10% more funds holding

Funds holding: 220 → 243 (+23)

0.31% less ownership

Funds ownership: 5% → 4.69% (-0.31%)

Holders
243
Holders Change
+23
Holders Change %
+10.45%
% of All Funds
4.9%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.18%
New
40
Increased
114
Reduced
55
Closed
15
Calls
$46.9M
Puts
$8.32M
Net Calls
+$38.5M
Net Calls Change
+$33.8M

Top Buyers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
+$380M
2
BBA
Baker Bros. Advisors
New York
+$358M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$261M
4
BC
Boxer Capital
California
+$44.5M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$44.5M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$85.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$69.5M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$60.4M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$42.2M
5
VanEck Associates
VanEck Associates
New York
-$17.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$3.95M +$563K +2,394 +21%
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$3.89M +$440K +1,874 +16%
OAM
103
Oppenheimer Asset Management
New York
$3.71M +$118K +504 +4%
EAM
104
Erste Asset Management
Austria
$3.66M -$3.43M -14,600 -53%
Public Employees Retirement Association of Colorado
105
Public Employees Retirement Association of Colorado
Colorado
$3.51M – – –
Handelsbanken Fonder
106
Handelsbanken Fonder
Sweden
$3.44M – – –
BNP Paribas Asset Management
107
BNP Paribas Asset Management
France
$3.41M +$239K +1,018 +9%
Victory Capital Management
108
Victory Capital Management
Texas
$3.36M -$94K -400 -3%
Stifel Financial
109
Stifel Financial
Missouri
$3.2M +$492K +2,095 +23%
LS
110
Livforsakringsbolaget Skandia
Sweden
$3.15M +$353K +1,500 +16%
DZ Bank
111
DZ Bank
Germany
$3.12M +$1.04M +4,411 +68%
Envestnet Asset Management
112
Envestnet Asset Management
Illinois
$3.07M +$464K +1,976 +23%
SAM
113
Storebrand Asset Management
Norway
$3.02M +$154K +657 +7%
GIBU
114
Gulf International Bank (UK)
United Kingdom
$2.83M +$235K +1,000 +11%
VIA
115
Vident Investment Advisory
Georgia
$2.78M -$255K -1,083 -10%
KBC Group
116
KBC Group
Belgium
$2.54M +$133K +564 +7%
Susquehanna International Group
117
Susquehanna International Group
Pennsylvania
$2.23M +$1.06M +4,530 +139%
SG Americas Securities
118
SG Americas Securities
New York
$2.17M +$979K +4,164 +122%
PAM
119
Panagora Asset Management
Massachusetts
$2.16M -$1.77M -7,528 -50%
Mitsubishi UFJ Asset Management
120
Mitsubishi UFJ Asset Management
Japan
$2.13M +$299K +1,272 +21%
FAF
121
Första AP-fonden
Sweden
$2.06M +$564K +2,400 +50%
ProShare Advisors
122
ProShare Advisors
Maryland
$2.02M +$75.2K +320 +5%
NIPH
123
NN Investment Partners Holdings
Netherlands
$1.95M +$23.5K +100 +1%
ACI
124
AMP Capital Investors
Australia
$1.93M +$51.2K +218 +3%
GC
125
Guggenheim Capital
Illinois
$1.89M -$2.32M -9,862 -60%
3 4
5
6 7

ONC Hedge Fund Activity: Q3 2020 in Review

243 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2020, worth a combined $15.7B — up 66% from $9.45B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ONC positions and 15 closed out — a net gain of 25 holders — while 114 added to existing stakes and 55 trimmed.

The largest buyer was Primecap Management, adding an estimated $380M. The largest seller was Fidelity Investments, cutting an estimated $85.9M.

  • 243 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2020, up from 220 in Q2 2020.
  • Funds reported $15.7B of BeOne Medicines Ltd stock for Q3 2020, up 66% quarter-over-quarter.
  • 40 funds opened new BeOne Medicines Ltd positions in Q3 2020 and 15 closed out, a net change of +25 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2020 was Primecap Management, an estimated $380M added.
  • The largest BeOne Medicines Ltd seller in Q3 2020 was Fidelity Investments, an estimated $85.9M sold.

Based on aggregated 13F filings for Q3 2020.